Eating, Drinking, and Traveling With Sickle Cell Disease: What the Research Supports

Deep-research Food-as-Medicine article on sickle cell disease, asking what the human research supports for eating, drinking, and traveling with SCD — and printing plainly where the record is null. CDC (Data and Statistics, May 15, 2024) estimates about 100,000 people affected in the United States, with SCD in about 1 in 365 Black or African American births; the CDC Sickle Cell Data Collection analysis of 2016-2020 newborn screening in 11 states (MMWR 2024; 3,305 confirmed newborns) measured 1 in 350 non-Hispanic Black newborns. In a randomized trial of 42 prepubertal children with sickle cell anemia (Zemel 2002, PMID 11815322), 10 mg/day of elemental zinc for 12 months produced significantly greater height gains (+0.66 cm/year vs. control) while control growth z scores fell. Vitamin D deficiency was present in 52.5% of participants at baseline in the only placebo-controlled trial (Osunkwo 2012, DOI 10.1111/bjh.12019; n=39), which found fewer pain days at 8 weeks (MD -10.00) but worse physical-functioning scores at 16-24 weeks; the Cochrane review (Soe 2020, PMID 32462740; 3 RCTs) concludes the evidence is not of sufficient quality to guide clinical practice. No trial has tested a prescribed daily water volume or a named diet pattern in SCD, and the air-travel literature is case reports without denominators (Wembonyama 2021, DOI 10.34172/ijtmgh.2022.02). No product is named or recommended; no supplement treats or cures SCD and care is physician-directed. Evidence grade: EMERGING. Educational article from the Buddha Ayurvedic School of Medicine: https://buddha.hospital